elzovantinib
Generic: TPX-0022·Code: TPX-0022
elzovantinib: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Turning Point Therapeutics, Inc. (TPTX) | Phase 1 |
Get deeper analysis on elzovantinib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis